2 completed, 1 not yet recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Not yet recruiting 1 |
Follow Tocilizumab biosimilar: new trials by email Literature Review of Tocilizumab biosimilar trials Research Report on Tocilizumab biosimilar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Trial of MK-6255 to Treat Endometrial and Ovarian Cancer (MK-6255-001) MK-6255, CD8 PET Tracer, Acetaminophen - Ovarian Neoplasms, Endometrial Neoplasms | Phase 1 | Not yet recruiting | Merck Sharp & Dohme LLC | 80 | 2026-11-13 | 2026-10-13 |
| A Safety and Pharmacokinetics Study of Complarate (Tocilizumab Biosimilar Solution) and Actemra® in Healthy Volunteers Complarate, Actemra® - Healthy Volunteers | Phase 1 | Completed | AO GENERIUM | 256 | 2024-06-20 | 2026-09-21 |
| A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers Complarate®, Actemra® - Healthy Volunteers | Phase 1 | Completed | AO GENERIUM | 43 | 2022-04-11 | 2024-07-01 |
Endometrial Neoplasms (1) · Ovarian Neoplasms (1)
AO GENERIUM (2) · Merck Sharp & Dohme LLC (1)
Russia (2)